Table of contents
Volume 91, Issue 6
Published online 10 September 2004 (1003-1227)
Minireview |
Clinical |
Molecular and Cellular Pathology |
Genetics and Genomics |
Experimental Therapeutics |
Letters to the Editor |
Corrigenda
Editorial
Chemotherapy for prostate cancer: small steps or leaps and bounds? No huzzahs just yet! FREE
D Raghavan
Br J Cancer 91: 1003-1004; doi:10.1038/sj.bjc.6602157
Minireview
Is there a role for chemotherapy in prostate cancer? FREE
C M Canil and I F Tannock
Br J Cancer 91: 1005-1011; advance online publication, April 27, 2004; doi:10.1038/sj.bjc.6601850
Clinical
Equal quality of life after limb-sparing or ablative surgery for lower extremity sarcomas FREE
A Zahlten-Hinguranage, L Bernd, V Ewerbeck and D Sabo
Br J Cancer 91: 1012-1014; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602104
RNA profiling of cyclooxygenases 1 and 2 in colorectal cancer FREE
R D Church, J Yu, J W Fleshman, W D Shannon, R Govindan and H L McLeod
Br J Cancer 91: 1015-1018; advance online publication, August 24, 2004; doi:10.1038/sj.bjc.6602119
A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer FREE
S Y K Ngan, M Michael, J Mackay, J McKendrick, T Leong, D Lim Joon and J R Zalcberg
Br J Cancer 91: 1019-1024; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602106
Allelic imbalance at 1p36 may predict prognosis of chemoradiation therapy for bladder preservation in patients with invasive bladder cancer FREE
H Matsumoto, H Matsuyama, K Fukunaga, S Yoshihiro, T Wada and K Naito
Br J Cancer 91: 1025-1031; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602073
Phase I–II study of irinotecan (CPT-11) plus nedaplatin (254-S) with recombinant human granulocyte colony-stimulating factor support in patients with advanced or recurrent cervical cancer FREE
H Tsuda, Y Hashiguchi, S Nishimura, M Miyama, S Nakata, N Kawamura and S Negoro
Br J Cancer 91: 1032-1037; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602076
Phase II trial of carboplatin and etoposide for patients with recurrent high-grade glioma FREE
E Franceschi, G Cavallo, L Scopece, A Paioli, A Pession, E Magrini, R Conforti, E Palmerini, S Bartolini, S Rimondini, R Degli Esposti and L Crinò
Br J Cancer 91: 1038-1044; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602105
Long-term outcome of radiological-guided insertion of implanted central venous access port devices (CVAPD) for the delivery of chemotherapy in cancer patients: institutional experience and review of the literature FREE
J Vardy, K Engelhardt, K Cox, J Jacquet, A McDade, M Boyer, P Beale, M Stockler, R Loneragan, B Dennien, R Waugh and S J Clarke
Br J Cancer 91: 1045-1049; advance online publication, August 17, 2004; doi:10.1038/sj.bjc.6602082
Psychosocial interventions for patients with advanced cancer – a systematic review of the literature FREE
R J Uitterhoeve, M Vernooy, M Litjens, K Potting, J Bensing, P De Mulder and T van Achterberg
Br J Cancer 91: 1050-1062; advance online publication, August 17, 2004; doi:10.1038/sj.bjc.6602103
Molecular and Cellular Pathology
The relationship between deprivation, tumour stage and the systemic inflammatory response in patients with primary operable breast cancer FREE
A M Al Murri, J C Doughty, A Lannigan, C Wilson, C S McArdle and D C McMillan
Br J Cancer 91: 1063-1065; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602096
Sustained antiproliferative mechanisms by RB24, a targeted precursor of multiple inhibitors of epidermal growth factor receptor and a DNA alkylating agent in the A431 epidermal carcinoma of the vulva cell line FREE
R Banerjee, Z Rachid, Q Qiu, J P McNamee, A M Tari and B J Jean-Claude
Br J Cancer 91: 1066-1073; advance online publication, September 7, 2004; doi:10.1038/sj.bjc.6602098
Abrogation of IL-6-mediated JAK signalling by the cyclopentenone prostaglandin 15d-PGJ2 in oral squamous carcinoma cells FREE
H Siavash, N G Nikitakis and J J Sauk
Br J Cancer 91: 1074-1080; advance online publication, August 17, 2004; doi:10.1038/sj.bjc.6602055
Upregulation of p16INK4A and Bax in p53 wild/p53-overexpressing crypts in ulcerative colitis-associated tumours FREE
T Yoshida, N Matsumoto, T Mikami and I Okayasu
Br J Cancer 91: 1081-1088; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602050
Reduced Apaf-1 expression in human cutaneous melanomas FREE
D L Dai, M Martinka, J A Bush and G Li
Br J Cancer 91: 1089-1095; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602092
Detection and molecular characterisation of thyroid cancer precursor lesions in a specific subset of Hashimoto's thyroiditis FREE
A Gasbarri, S Sciacchitano, A Marasco, M Papotti, A Di Napoli, A Marzullo, P Yushkov, L Ruco and A Bartolazzi
Br J Cancer 91: 1096-1104; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602097
Identification of two contiguous minimally deleted regions on chromosome 1p36.31–p36.32 in oligodendroglial tumours FREE
Z Dong, JC-S Pang, M H Ng, W S Poon, L Zhou and H-K Ng
Br J Cancer 91: 1105-1111; doi:10.1038/sj.bjc.6602093
Genetics and Genomics
Comprehensive analysis of the 9p21 region in neuroblastoma suggests a role for genes mapping to 9p21–23 in the biology of favourable stage 4 tumours FREE
J Mora, M Alaminos, C de Torres, P Illei, J Qin, N-K V Cheung and W L Gerald
Br J Cancer 91: 1112-1118; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602094
A novel 1p36.2 located gene, APITD1, with tumour-suppressive properties and a putative p53-binding domain, shows low expression in neuroblastoma tumours FREE
C Krona, K Ejeskär, H Carén, F Abel, R-M Sjöberg and T Martinsson
Br J Cancer 91: 1119-1130; advance online publication, August 24, 2004; doi:10.1038/sj.bjc.6602083
Frequent downregulation of 14-3-3 
protein and hypermethylation of 14-3-3 gene in salivary gland adenoid cystic carcinoma FREE
D Uchida, N-M Begum, A Almofti, H Kawamata, H Yoshida and M Sato
Br J Cancer 91: 1131-1138; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602004
Methylation pattern of CDH13 gene in digestive tract cancers FREE
K Hibi, Y Kodera, K Ito, S Akiyama and A Nakao
Br J Cancer 91: 1139-1142; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602095
Allelic losses on chromosome 3p are accumulated in relation to morphological changes of lung adenocarcinoma FREE
H Iijima, Y Tomizawa, K Dobashi, R Saito, T Nakajima and M Mori
Br J Cancer 91: 1143-1148; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602005
METH-2 silencing and promoter hypermethylation in NSCLC FREE
J R Dunn, D Panutsopulos, M W Shaw, J Heighway, R Dormer, E N Salmo, S G Watson, J K Field and T Liloglou
Br J Cancer 91: 1149-1154; advance online publication, August 24, 2004; doi:10.1038/sj.bjc.6602107
Dosage analysis of cancer predisposition genes by multiplex ligation-dependent probe amplification FREE
D J Bunyan, D M Eccles, J Sillibourne, E Wilkins, N Simon Thomas, J Shea-Simonds, P J Duncan, C E Curtis, D O Robinson, J F Harvey and N C P Cross
Br J Cancer 91: 1155-1159; doi:10.1038/sj.bjc.6602121
Balancing false positives and false negatives for the detection of differential expression in malignancies FREE
F De Smet, Y Moreau, K Engelen, D Timmerman, I Vergote and B De Moor
Br J Cancer 91: 1160-1165; advance online publication, August 31, 2004; doi:10.1038/sj.bjc.6602140
Experimental Therapeutics
Effects of gemcitabine on APE/ref-1 endonuclease activity in pancreatic cancer cells, and the therapeutic potential of antisense oligonucleotides FREE
J P Lau, K L Weatherdon, V Skalski and D W Hedley
Br J Cancer 91: 1166-1173; advance online publication, August 17, 2004; doi:10.1038/sj.bjc.6602080
The tyrosine kinase inhibitor ZD6474 inhibits tumour growth in an intracerebral rat glioma model FREE
M Sandström, M Johansson, U Andersson, A Bergh, A T Bergenheim and R Henriksson
Br J Cancer 91: 1174-1180; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602108
Microenvironmental adaptation of experimental tumours to chronic vs acute hypoxia FREE
O Thews, T Wolloscheck, W Dillenburg, S Kraus, D K Kelleher, M A Konerding and P Vaupel
Br J Cancer 91: 1181-1189; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602066
The efficacy of Herceptin therapies is influenced by the expression of other erbB receptors, their ligands and the activation of downstream signalling proteins FREE
B L Smith, D Chin, W Maltzman, K Crosby, G N Hortobagyi and S S Bacus
Br J Cancer 91: 1190-1194; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602090
Recombinant humanised anti-HER2/neu antibody (Herceptin®) induces cellular death of glioblastomas FREE
J-F Mineo, A Bordron, I Quintin-Roué, S Loisel, K L Ster, V Buhé, N Lagarde and C Berthou
Br J Cancer 91: 1195-1199; advance online publication, August 24, 2004; doi:10.1038/sj.bjc.6602089
A human, compact, fully functional anti-ErbB2 antibody as a novel antitumour agent FREE
C De Lorenzo, A Tedesco, G Terrazzano, R Cozzolino, P Laccetti, R Piccoli and G D'Alessio
Br J Cancer 91: 1200-1204; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602110
No topoisomerase I alteration in a neuroblastoma model with in vivo acquired resistance to irinotecan FREE
L Calvet, A Santos, A Valent, M-J Terrier-Lacombe, P Opolon, J-L Merlin, G Aubert, J Morizet, J H M Schellens, J Bénard and G Vassal
Br J Cancer 91: 1205-1212; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602079
Characterisation of metabolites of the putative cancer chemopreventive agent quercetin and their effect on cyclo-oxygenase activity FREE
D J L Jones, J H Lamb, R D Verschoyle, L M Howells, M Butterworth, C K Lim, D Ferry, P B Farmer and A J Gescher
Br J Cancer 91: 1213-1219; advance online publication, August 3, 2004; doi:10.1038/sj.bjc.6602091
Letters to the Editor
Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer FREE
C Alliot
Br J Cancer 91: 1220-1221; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602100
Reply: Adjuvant immunochemotherapy with oral Tegafur/Uracil plus PSK in patients with stage II or III colorectal cancer FREE
S Ohwada and Y Morishita
Br J Cancer 91: 1221-1223; advance online publication, August 10, 2004; doi:10.1038/sj.bjc.6602101
Lymphatic vessel density and prognosis in cutaneous melanoma FREE
O Straume and L A Akslen
Br J Cancer 91: 1224-1225; advance online publication, August 17, 2004; doi:10.1038/sj.bjc.6602122
Corrigenda
Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study FREE
T Bjørge, A Engeland, T Luostarinen, J Mork, R E Gislefoss, E Jellum, P Koskela, M Lehtinen, E Pukkala, S Ø Thoresen and J Dillner
Br J Cancer 91: 1226; doi:10.1038/sj.bjc.6602116
Serum levels of IL-6 and TNF-
correlate with clinicopathological features and patient survival in patients with prostate cancer FREE
V Michalaki, K Syrigos, P Charles and J Waxman
Br J Cancer 91: 1227; doi:10.1038/sj.bjc.6602115
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
